1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | Continued from 9099A...
Complainant states that facility has been administering scheduled morphine but there are no nurses on site at facility. During investigation, LPA reviewed orders for all those residents prescribed morphine. All orders for liquid morphine are filled by the pharmacy via pre-filled/pre-dosed syringes and it is delivered via syringe for self-administration. Complaint alleges residents (R6 and R7) uses a zinc menthol cream, but the cream was never reordered when out of stock. Complainant states facility has instructed staff to use regular zinc cream without the menthol on the residents. LPA reviewed medication orders for R6 and R7. R7 did not have an active prescription for zinc menthol cream. R6 did have a prescription for both menthol and zinc cream. LPA reviewed e-MAR for R6. LPA observed e-MAR entries for R6 indicating the zinc cream was listed as “DNA” which stands for drug not available. During investigation, LPA conducted interviews. Facility Admin reported that when she became aware of the medication being listed as DNA on the e-Mar, she held a staff meeting to find out what the issue was. Per Admin, the zinc menthol cream was never out of stock, rather it was being stored in the resident’s bedside drawer rather than medication cart. However, not all staff were informed that the cream was being stored in the bedside table. Prescribed medications that may not be handled by the resident are required to be centrally stored. During investigation, LPA conducted interviews, six (6) out of eight (8) staff report that R1’s cream was stored bedside. Additionally, five (5) out of five (5) staff reported that when a medication is marked “DNA” in the e-MAR nothing is given in its place, because the drug is not available. So, based on LPA’s interviews and record review, the preponderance of evidence standard has been met, therefore the above allegation is found to be SUBSTANTIATED. California Code of Regulations, Title 22, Division 6 Chapter 8, are being cited on the attached 9099D.
Deficiencies cited from the California Code of Regulations, Title 22, Division 6 of California Regulation and the Health and Safety Code. Appeal rights given. Failure to correct the deficiency and/or repeat deficiencies within a 12 month period may result in civil penalties. Exit interview conducted with Administrator and a copy of this report was given.
|